These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 15682975)
1. A study on transmission and a trial of chemoprophylaxis in contacts of leprosy patients: design, methodology and recruitment findings of COLEP. Moet FJ; Oskam L; Faber R; Pahan D; Richardus JH Lepr Rev; 2004 Dec; 75(4):376-88. PubMed ID: 15682975 [TBL] [Abstract][Full Text] [Related]
2. Patient-related factors predicting the effectiveness of rifampicin chemoprophylaxis in contacts: 6 year follow up of the COLEP cohort in Bangladesh. Feenstra SG; Pahan D; Moet FJ; Oskam L; Richardus JH Lepr Rev; 2012 Sep; 83(3):292-304. PubMed ID: 23356030 [TBL] [Abstract][Full Text] [Related]
3. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years. Sharma P; Mukherjee R; Talwar GP; Sarathchandra KG; Walia R; Parida SK; Pandey RM; Rani R; Kar H; Mukherjee A; Katoch K; Benara SK; Singh T; Singh P Lepr Rev; 2005 Jun; 76(2):127-43. PubMed ID: 16038246 [TBL] [Abstract][Full Text] [Related]
4. Close contacts with leprosy in newly diagnosed leprosy patients in a high and low endemic area: comparison between Bangladesh and Thailand. Richardus JH; Meima A; van Marrewijk CJ; Croft RP; Smith TC Int J Lepr Other Mycobact Dis; 2005 Dec; 73(4):249-57. PubMed ID: 16830634 [TBL] [Abstract][Full Text] [Related]
5. Physical distance, genetic relationship, age, and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy. Moet FJ; Pahan D; Schuring RP; Oskam L; Richardus JH J Infect Dis; 2006 Feb; 193(3):346-53. PubMed ID: 16388481 [TBL] [Abstract][Full Text] [Related]
6. Role of contact tracing and prevention strategies in the interruption of leprosy transmission. Smith WC; Aerts A Lepr Rev; 2014 Mar; 85(1):2-17. PubMed ID: 24974438 [TBL] [Abstract][Full Text] [Related]
7. Transmission of leprosy within households. Rao PS; Karat AB; Kaliaperumal VG; Karat S Int J Lepr Other Mycobact Dis; 1975; 43(1):45-54. PubMed ID: 1171831 [TBL] [Abstract][Full Text] [Related]
8. Intrafamilial transmission of leprosy in Vellore Town, India. George R; Rao PS; Mathai R; Jacob M Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):550-5. PubMed ID: 8151185 [TBL] [Abstract][Full Text] [Related]
9. Low predictive value of PGL-I serology for the early diagnosis of leprosy in family contacts: results of a 10-year prospective field study in French Polynesia. Chanteau S; Glaziou P; Plichart C; Luquiaud P; Plichart R; Faucher JF; Cartel JL Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):533-41. PubMed ID: 8151183 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for developing leprosy--a population-based cohort study in Indonesia. Bakker MI; Hatta M; Kwenang A; Van Mosseveld P; Faber WR; Klatser PR; Oskam L Lepr Rev; 2006 Mar; 77(1):48-61. PubMed ID: 16715690 [TBL] [Abstract][Full Text] [Related]
11. Population survey to determine risk factors for Mycobacterium leprae transmission and infection. Bakker MI; Hatta M; Kwenang A; Faber WR; van Beers SM; Klatser PR; Oskam L Int J Epidemiol; 2004 Dec; 33(6):1329-36. PubMed ID: 15256520 [TBL] [Abstract][Full Text] [Related]
12. The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study). Richardus RA; Alam K; Pahan D; Feenstra SG; Geluk A; Richardus JH BMC Infect Dis; 2013 Oct; 13():456. PubMed ID: 24088534 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions. Moet FJ; Meima A; Oskam L; Richardus JH Lepr Rev; 2004 Dec; 75(4):310-26. PubMed ID: 15682969 [TBL] [Abstract][Full Text] [Related]
14. Chemoprophylaxis of leprosy with a single dose of 25 mg per kg rifampin in the southern Marquesas; results after four years. Cartel JL; Chanteau S; Moulia-Pelat JP; Plichart R; Glaziou P; Boutin JP; Roux JF; Grosset JH Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):416-20. PubMed ID: 1474280 [TBL] [Abstract][Full Text] [Related]
15. Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention. Schuring RP; Richardus JH; Pahan D; Oskam L Vaccine; 2009 Nov; 27(50):7125-8. PubMed ID: 19786134 [TBL] [Abstract][Full Text] [Related]
16. The prognostic importance of detecting mild sensory impairment in leprosy: a randomized controlled trial (TRIPOD 2). Van Brakel WH; Anderson AM; Withington SG; Croft RP; Nicholls PG; Richardus JH; Smith WC Lepr Rev; 2003 Dec; 74(4):300-10. PubMed ID: 14750575 [TBL] [Abstract][Full Text] [Related]
17. Chemoprophylaxis of leprosy with rifampicin in contacts of multibacillary patients: study protocol for a randomized controlled trial. Dos Santos DS; Duppre NC; Sarno EN; Pinheiro RO; Sales AM; Nery JADC; Moraes MO; Camacho LAB Trials; 2018 Apr; 19(1):244. PubMed ID: 29685164 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of single-dose rifampicin after BCG vaccination to prevent leprosy in close contacts of patients with newly diagnosed leprosy: A cluster randomized controlled trial. Richardus R; Alam K; Kundu K; Chandra Roy J; Zafar T; Chowdhury AS; Nieboer D; Faber R; Butlin CR; Geluk A; Richardus JH Int J Infect Dis; 2019 Nov; 88():65-72. PubMed ID: 31499206 [TBL] [Abstract][Full Text] [Related]
19. Transmission of Hansen's disease and unscreened household contacts. Ignotti E; Bayona M; Alvarez-Garriga C; Andrade VL; Valente JG Indian J Lepr; 2007; 79(1):11-25. PubMed ID: 17578265 [TBL] [Abstract][Full Text] [Related]
20. Prevention of leprosy using rifampicin as chemoprophylaxis. Bakker MI; Hatta M; Kwenang A; Van Benthem BH; Van Beers SM; Klatser PR; Oskam L Am J Trop Med Hyg; 2005 Apr; 72(4):443-8. PubMed ID: 15827283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]